PL2199303T3 - Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia - Google Patents

Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia

Info

Publication number
PL2199303T3
PL2199303T3 PL08021660T PL08021660T PL2199303T3 PL 2199303 T3 PL2199303 T3 PL 2199303T3 PL 08021660 T PL08021660 T PL 08021660T PL 08021660 T PL08021660 T PL 08021660T PL 2199303 T3 PL2199303 T3 PL 2199303T3
Authority
PL
Poland
Prior art keywords
polypeptides
antibodies
patients
borrelia infection
specific metering
Prior art date
Application number
PL08021660T
Other languages
English (en)
Inventor
Lars Komorowski
Christian Probst
Anthonina Janssen
Winfried Stoecker
Original Assignee
Euroimmun Medizinische Labordiagnostika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40568393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2199303(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euroimmun Medizinische Labordiagnostika Ag filed Critical Euroimmun Medizinische Labordiagnostika Ag
Publication of PL2199303T3 publication Critical patent/PL2199303T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
PL08021660T 2008-12-12 2008-12-12 Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia PL2199303T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08021660.9A EP2199303B1 (de) 2008-12-12 2008-12-12 Polypeptide und Verfahren zur spezifischen Detektion von Antikörpern bei Patienten mit einer Borrelieninfektion

Publications (1)

Publication Number Publication Date
PL2199303T3 true PL2199303T3 (pl) 2013-11-29

Family

ID=40568393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08021660T PL2199303T3 (pl) 2008-12-12 2008-12-12 Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia

Country Status (4)

Country Link
US (2) US8163500B2 (pl)
EP (1) EP2199303B1 (pl)
ES (1) ES2421885T3 (pl)
PL (1) PL2199303T3 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2959971A1 (de) 2014-06-27 2015-12-30 Euroimmun Medizinische Labordiagnostika AG Verfahren und Vorrichtung zur Überführung von Flüssigkeiten
WO2016049148A1 (en) 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions and methods for te diagnosis of lyme disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072008C (en) 1989-12-22 2003-01-28 Renate Fuchs Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
EP1741718A3 (en) 1995-06-07 2007-03-28 Sanofi Pasteur Inc. Expression of lipoproteins
EP0896583B1 (en) 1996-05-02 2003-02-05 Dako A/S Use of peptide fragments derived from osp-c for diagnostic methods
AT405940B (de) * 1996-06-21 1999-12-27 Immuno Ag Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein

Also Published As

Publication number Publication date
EP2199303A1 (de) 2010-06-23
US8163500B2 (en) 2012-04-24
US20100150964A1 (en) 2010-06-17
US20120177680A1 (en) 2012-07-12
ES2421885T3 (es) 2013-09-06
EP2199303B1 (de) 2013-06-05
US8431135B2 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
IL250624A0 (en) Anti-fgfr3 antibodies and methods of using them
IL248723B (en) Specific antibodies against the bcr complex and methods of using them
IL245984A0 (en) Antibodies and medical preparations containing them for the treatment of hypoglycemia or insulin sensitivity
EP2350655A4 (en) METHODS OF USING ANTIBODIES AND THEIR ANALOGUES
ZA201202560B (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
HUE042940T2 (hu) Anti-FXI antitestek és alkalmazási eljárások
EP2219020A4 (en) SYSTEM AND METHOD FOR MEASURING THE BLOOD-FLOWING CAPACITY
IL211623A0 (en) Anti-notch2 antibodies and methods of use
HK1165752A1 (en) Method and device for providing blood constituents
EP2396034A4 (en) ANTIBODIES AND METHODS FOR TREATING DISEASES ASSOCIATED WITH A STROGEN RECEPTOR
ZA201008748B (en) Humanized antibodies against human interferon-alpha
GB0807018D0 (en) Antibodies and treatment
EP2453213A4 (en) Measuring device and measuring method for continuous physical quantity
IL212795A0 (en) Fully human antibodies against n-cadherin
GB201009713D0 (en) A pharmaceutical composition for treating diabetes and preparation methods thereof
PL2435348T3 (pl) Urządzenie do pobierania materiału w postaci proszku i sposób pobierania materiału w postaci proszku do cieczy
EP2388320A4 (en) ANTI-HS6ST2 ANTIBODIES AND USE THEREOF
IL219136A0 (en) Anti-hepsin antibodies and methods using same
KR101030035B9 (ko) 스피루리나를 함유하는 쌀엿강정 및 그 제조방법
PL2199303T3 (pl) Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia
GB0808090D0 (en) Use of magnetic proteins in medicine
PL2110402T3 (pl) Preparat środka polepszającego przyczepność oraz sposób obróbki wkładek wzmacniających
HK1147929A1 (en) Set for determining blood type and cover body
EP2484693A4 (en) ANTI-AMYLOID-A3 ANTIBODIES OF HUMAN SERUM AND USE THEREOF
IL210428A (en) Apadnosone dosing unit and method of use